上海交通大学学报（医学版）2026，Vol.46Issue(4)：415-426,12.DOI:10.3969/j.issn.1674-8115.2026.04.001
调节性T细胞基础机制研究突破和临床转化前景
Breakthroughs in basic mechanism research and clinical translation prospects of regulatory T cells
摘要
Abstract
Immune tolerance serves as the core cornerstone for maintaining the homeostasis of the body's immune system.Once this sophisticated regulatory mechanism is disrupted,it will directly induce a series of major diseases,including autoimmune diseases such as rheumatoid arthritis and systemic lupus erythematosus,as well as tumor immune escape and organ transplant rejection,seriously endangering human life and health.The 2025 Nobel Prize in Physiology or Medicine was awarded to Mary E.Brunkow,Fred Ramsdell,and Shimon Sakaguchi in recognition of their pioneering contributions to the field of peripheral immune tolerance—successfully identifying CD4+CD25+FOXP3+regulatory T cells(Treg)and their core regulatory gene,forkhead box P3(FOXP3),and establishing the core theoretical framework of the"FOXP3-Treg-immune tolerance"axis,which has laid a solid foundation for subsequent research in this field.This review systematically combs the historical context of Treg and FOXP3 research,clearly presenting the evolutionary trajectory of the field from the early exploration of immune tolerance phenomena to the identification of key cell subsets and regulatory genes.It focuses on key advances in recent years,comprehensively covering core contents such as the refined classification and developmental characteristics of Treg subtypes,the multi-dimensional expansion of the FOXP3 regulatory network,the functional mechanisms of Treg in various diseases,and breakthrough achievements in clinical translation.Finally,focusing on the bottlenecks in the clinical translation of Treg therapies,this review provides perspectives on future development directions.关键词
调节性T细胞/叉头框蛋白P3/免疫耐受/免疫稳态/临床转化Key words
regulatory T cell(Treg)/forkhead box P3(FOXP3)/immune tolerance/immune homeostasis/clinical translation分类
医药卫生引用本文复制引用
王震,张楠,沈艺冰,李丹,彭程,顾志冬,李斌..调节性T细胞基础机制研究突破和临床转化前景[J].上海交通大学学报（医学版）,2026,46(4):415-426,12.基金项目
国家自然科学基金(82441047,82241222,32130041) （82441047,82241222,32130041）
国家科技重大专项(2023ZD0501605). National Natural Science Foundation of China(82441047,82241222,32130041) （2023ZD0501605）
National Science and Technology Major Project(2023ZD0501605). （2023ZD0501605）
